Neogen Chemicals Limited manufacturers of bromine and lithium based specialty chemicals in India.
High growth potential with proven track record.
Share Price & News
How has Neogen Chemicals's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: NEOGEN's share price has been volatile over the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: NEOGEN exceeded the Indian Chemicals industry which returned 17.2% over the past year.
Return vs Market: NEOGEN exceeded the Indian Market which returned 1.6% over the past year.
Price Volatility Vs. Market
How volatile is Neogen Chemicals's share price compared to the market and industry in the last 5 years?
Simply Wall St News
5 days ago | Simply Wall StNeogen Chemicals Limited's (NSE:NEOGEN) Share Price Matching Investor Opinion
2 weeks ago | Simply Wall StDoes Neogen Chemicals Limited (NSE:NEOGEN) Have A Place In Your Dividend Portfolio?
3 weeks ago | Simply Wall StDoes Neogen Chemicals' (NSE:NEOGEN) Share Price Gain of 61% Match Its Business Performance?
Is Neogen Chemicals undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: NEOGEN (₹611) is trading above our estimate of fair value (₹75.03)
Significantly Below Fair Value: NEOGEN is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: NEOGEN is poor value based on its PE Ratio (49.8x) compared to the IN Chemicals industry average (11.8x).
PE vs Market: NEOGEN is poor value based on its PE Ratio (49.8x) compared to the Indian market (13.2x).
Price to Earnings Growth Ratio
PEG Ratio: NEOGEN is poor value based on its PEG Ratio (1.8x)
Price to Book Ratio
PB vs Industry: NEOGEN is overvalued based on its PB Ratio (9.1x) compared to the IN Chemicals industry average (1x).
How is Neogen Chemicals forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NEOGEN's forecast earnings growth (27.8% per year) is above the savings rate (7.2%).
Earnings vs Market: NEOGEN's earnings (27.8% per year) are forecast to grow faster than the Indian market (21.9% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: NEOGEN's revenue (18.5% per year) is forecast to grow faster than the Indian market (9.6% per year).
High Growth Revenue: NEOGEN's revenue (18.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: NEOGEN's Return on Equity is forecast to be high in 3 years time (25%)
How has Neogen Chemicals performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: NEOGEN has a high level of non-cash earnings.
Growing Profit Margin: NEOGEN's current net profit margins (9.4%) are higher than last year (8.8%).
Past Earnings Growth Analysis
Earnings Trend: NEOGEN's earnings have grown significantly by 31% per year over the past 5 years.
Accelerating Growth: NEOGEN's earnings growth over the past year (36.6%) exceeds its 5-year average (31% per year).
Earnings vs Industry: NEOGEN earnings growth over the past year (36.6%) exceeded the Chemicals industry 3.7%.
Return on Equity
High ROE: NEOGEN's Return on Equity (18.3%) is considered low.
How is Neogen Chemicals's financial position?
Financial Position Analysis
Short Term Liabilities: NEOGEN's short term assets (₹2.3B) exceed its short term liabilities (₹1.5B).
Long Term Liabilities: NEOGEN's short term assets (₹2.3B) exceed its long term liabilities (₹487.4M).
Debt to Equity History and Analysis
Debt Level: NEOGEN's debt to equity ratio (84.7%) is considered high.
Reducing Debt: NEOGEN's debt to equity ratio has reduced from 102.9% to 84.7% over the past 5 years.
Debt Coverage: NEOGEN's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: NEOGEN's interest payments on its debt are well covered by EBIT (4.4x coverage).
What is Neogen Chemicals's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: NEOGEN's dividend (0.33%) isn’t notable compared to the bottom 25% of dividend payers in the Indian market (0.66%).
High Dividend: NEOGEN's dividend (0.33%) is low compared to the top 25% of dividend payers in the Indian market (2.76%).
Stability and Growth of Payments
Stable Dividend: Too early to tell whether NEOGEN's dividend payments have been stable as they only just started paying a dividend.
Growing Dividend: Too early to tell if NEOGEN's dividend payments are increasing as they only just started paying a dividend.
Current Payout to Shareholders
Dividend Coverage: With its low payout ratio (16.3%), NEOGEN's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: NEOGEN's dividends in 3 years are forecast to be thoroughly covered by earnings (11.9% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Haridas Kanani (74 yo)
Mr. Haridas Thakarshi Kanani serves as the Chairman and Managing Director at Neogen Chemicals Limited. He oversees the manufacturing, research and development and general operation and management of Neogen ...
CEO Compensation Analysis
Compensation vs Market: Haridas's total compensation ($USD63.32K) is below average for companies of similar size in the Indian market ($USD328.40K).
Compensation vs Earnings: Haridas's compensation has increased by more than 20% in the past year.
|Chairman & MD||no data||₹4.76m||55.74% |
|Joint MD & Director||3.58yrs||₹4.30m||8.59% |
|Executive Director||no data||₹4.13m||0.00034% |
|Non Executive Director||no data||no data||1.29% |
|Independent Director||5.83yrs||₹60.00k||0.011% |
|Independent Director||5.83yrs||₹120.00k||0.00015% |
|Independent Director||1.83yrs||₹100.00k||no data|
|Independent Director||1.83yrs||₹50.00k||no data|
Experienced Board: NEOGEN's board of directors are considered experienced (3.6 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: NEOGEN insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Neogen Chemicals Limited's company bio, employee growth, exchange listings and data sources
- Name: Neogen Chemicals Limited
- Ticker: NEOGEN
- Exchange: NSEI
- Founded: 1989
- Industry: Specialty Chemicals
- Sector: Materials
- Market Cap: ₹13.848b
- Shares outstanding: 23.33m
- Website: https://www.neogenchem.com
Number of Employees
- Neogen Chemicals Limited
- Dev Corpora Building
- Office No. 1002, 10th Floor
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|542665||BSE (Mumbai Stock Exchange)||Yes||Equity Shares||IN||INR||May 2019|
|NEOGEN||NSEI (National Stock Exchange of India)||Yes||Equity Shares||IN||INR||May 2019|
Neogen Chemicals Limited manufacturers of bromine and lithium based specialty chemicals in India. It offers organic chemicals, such as alkyl bromide compounds, dibromo alkane compounds, and bromo chloro al ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/08/04 12:41|
|End of Day Share Price||2020/08/04 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.